Concepedia

Matthias Rabiller

MR

Statistics

Publications

11

Citations

1.5K

H-Index

11

Active since

2006

Affiliations

Chemical Genomics Centre(Current)

Max Planck Society

Max Planck Institute of Molecular Physiology

University of Duisburg-Essen

Stellenbosch University

Matthias Rabiller is an author at Chemical Genomics Centre specializing in drug discovery, kinase inhibitors, and pharmacology.

Publications per year

2006–2012

11

Publications

11

Specification of SUMO1- and SUMO2-interacting Motifs

Christina-Maria Hecker, Matthias Rabiller, Kaisa Haglund et al. · Journal of Biological Chemistry · 2006 · 581 citations · Full text

, , +11

Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation

Martin L. Sos, Haridas B. Rode, Stefanie Heynck et al. · Cancer Research · 2010 · 219 citations · Full text

, , +15

Development of a Fluorescent-Tagged Kinase Assay System for the Detection and Characterization of Allosteric Kinase Inhibitors

Jeffrey R. Simard, Matthäus Getlik, Christian Grütter et al. · Journal of the American Chemical Society · 2009 · 149 citations

, , +13

Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc

Matthäus Getlik, Christian Grütter, Jeffrey R. Simard et al. · Journal of Medicinal Chemistry · 2009 · 143 citations · Full text

, , +15

A new screening assay for allosteric inhibitors of cSrc

Jeffrey R. Simard, Sabine Klüter, Christian Grütter et al. · Nature Chemical Biology · 2009 · 125 citations · Full text

, , +14

1–5 of 11